A-ha frontman Morten Harket reveals Parkinson's diagnosis
The 'Take On Me' singer told biographer Jan Omdahl that he underwent a procedure for deep brain stimulation (DBS) in June 2024, addressing the left side of his brain, and a similar one in December for the right.
Parkinson's causes parts of one's brain to deteriorate and affects muscle control, balance and movement, as well as thinking ability and mental health, according to the Cleveland Clinic.
'The simple fact that, on good days, Morten shows virtually no sign of many of the most familiar physical symptoms of Parkinson's, doesn't mean that he is well,' wrote Omdahl, who penned the Norwegian band's 2003 biography, 'The Swing of Things.'
Omdahl recounted Harket's 'round-the-clock effort to balance medication, signals from the electrodes in his brain, sleep, blood sugar and mindset in a way that keeps the symptoms and side effects more or less in check,' though it 'isn't always successful.'
Harket said he doesn't 'expect to be able to achieve full technical control' of his voice anymore, even as he works on unreleased music.
'The question is whether I can express myself with my voice,' he told Omdahl. 'As things stand now, that's out of the question.'
Harket, however, told fans not to worry and instead 'spend your energy and effort addressing real problems, and know that I am being taken care of.'
A-ha — a synth-pop trio whose members also include Magne Furuholmen and Paul Waaktaar-Savoy — is best known for their 1980s hits 'Take On Me,' 'Cry Wolf' and 'The Sun Always Shines on TV.' The band split in 2009 but briefly reunited in 2015.
The music video for 'Take On Me' hit 1 billion views in early 2020 and crossed the 2 billion-view threshold this past September.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
6 hours ago
- Yahoo
The spicy favorite that can help protect your vision and your heart
This spicy favorite packs a punch during dinner – and keeps your heart and eyes healthy. Whether powdered, dried, or fresh, cayenne pepper has a bushel-load of vitamins. Specifically, it contains vitamin A, which is essential to our eye, organ, reproductive, and immune system health. 'In just one teaspoon, you'll get 15 percent of your daily vitamin A,' registered dietitian Alexis Supan told the Cleveland Clinic. She noted that people can consume even more vitamins from the fresh peppers. Botanically considered to be fruits and culinarily known as vegetables, the shockingly red spice also has vitamins B6, K, and C. Vitamin K helps the body to stop bleeding and fortifies bone health. Vitamin C, often taken in tablets, supports our immune system. 'One fresh pepper has 72 percent of the recommended daily amount of vitamin C and 50 percent of vitamin A,' Supan noted. The peppers are a great source of antioxidants that protect our cells and promote health, according to Supan. Diets that are high in antioxidants have been shown to help stave off cancer and heart disease. Cayenne peppers have capsaicin, which is the chemical compound that makes them so hot. Dozens of studies show that capsaicin protects against inflammation, which can significantly contribute to the development and progression of cancer. Supan said the peppers may also aid blood flow and lower blood pressure. High blood pressure can lead to an increased risk of heart disease: America's top killer. Similarly to other spicy favorites with capsaicin, there's evidence that they may help to burn calories and feel fuller after eating. 'Cayenne pepper is really helpful for digestion,' Supan said. 'It increases gastric juices and enzyme production in the stomach, which helps us break down food.' Most people can buy the powder and peppers at their local grocery stores. Hotter than a jalapeño, these peppers are around 30,000 to 50,000 Scoville Heat Units, the scale that measures the heat of a chili pepper. For context, the Carolina reapers – some of the hottest peppers in the world – are measured at 2.2 million units. Still, it's probably not something to put directly in your mouth. But, if you can stand the heat, experts say the benefits of cayenne pepper stand the test of time. Its use dates back more than 7,000 years to ancient Central and South America. Still, make sure not do overdo it. You just need a pinch! 'Cayenne peppers are a great addition to a healthy diet,' said Supan.
Associated Press
8 hours ago
- Associated Press
KnoWEwell Appoints Dr. Patrick Hanaway as Chief Medical Officer
BEDMINSTER, N.J.--(BUSINESS WIRE)--Aug 13, 2025-- KnoWEwell, the global Regenerative Whole Health benefits and services company, is proud to announce the appointment of Dr. Patrick Hanaway as its new Chief Medical Officer (CMO). This press release features multimedia. View the full release here: Dr. Patrick Hanaway, Chief Medical Officer, KnoWEwell P.B.C. Dr. Hanaway is a pioneer in functional medicine and the former founding director of the Cleveland Clinic Center for Functional Medicine. Dr. Hanaway brings a wealth of knowledge, expertise and focused research on evaluating the outcomes of functional medicine models of care through education and clinical care. 'Over the last eight years, I have come to know Kimberly Whittle, KnoWEwell's founder and CEO, and have been watching the organization grow and flourish. I am excited to be joining KnoWEwell at a pivotal time in its growth and look forward to implementing transformational protocols and expanding our collaborative partnership through the Regenerative Whole Health Hub, a trusted, global ecosystem, community, and marketplace.' Under Dr. Hanaway's guidance, KnoWEwell aims to further its mission of transforming healthcare by empowering individuals, practitioners, and organizations with the Regenerative Whole Health knowledge, resources and ecosystem community to prevent harm and address the root causes of chronic disease. Dr. Hanaway's leadership will be instrumental in expanding access to affordable, evidence-based protocols to promote WELLthier Living for members worldwide. Ms. Whittle remarked on the milestone, saying, 'Had I not seen Dr. Hanaway speak on functional medicine, my family might not have healed and KnoWEwell might not have been born. It is a great honor to have Dr. Hanaway join KnoWEwell's family as our Chief Medical Officer.' In addition to Dr. Hanaway's notable accomplishments, he has been initiated as a Mara'akame (Indigenous healer) by the Huichol people of the Sierra Madre in Mexico. He holds community fires, leads ceremonies, and offers traditional healing sessions. Ms. Whittle adds, 'Dr. Hanaway's work aligns seamlessly with KnoWEwell's vision to connect the dots between soil, food, nutrition, lifestyle, community, people and planet health and well-being to complement KnoWEwell's goal of transforming healthcare.' For more information and to join KnoWEwell's RWH Hub visit KnoWEwell P.B.C. KnoWEwell, P.B.C. operates the Regenerative Whole Health Hub, the trusted global digital ecosystem, community, and marketplace that bridges the knowledge, access, and insurance gaps to proactively prevent and address the root causes of chronic disease and help individuals, practitioners, nonprofits and businesses thrive. KnoWEwell also owns Natural Awakenings Publishing Corporation, the operator of the Natural Awakenings magazine franchise system. The magazine promotes natural and holistic health, and a sustainable, green lifestyle. It reaches approximately 1.3+ million monthly readers in markets across the United States. View source version on CONTACT: Media KnoWEwell, P.B.C. Public Relations 855.593.9355 [email protected] KEYWORD: UNITED STATES NORTH AMERICA NEW JERSEY INDUSTRY KEYWORD: GENERAL HEALTH HEALTH INSURANCE HEALTH PRACTICE MANAGEMENT SOURCE: KnoWEwell Copyright Business Wire 2025. PUB: 08/13/2025 05:06 AM/DISC: 08/13/2025 05:05 AM
Business Insider
11 hours ago
- Business Insider
Gain Therapeutics price target lowered to $6 from $7 at Roth Capital
Roth Capital lowered the firm's price target on Gain Therapeutics (GANX) to $6 from $7 and keeps a Buy rating on the shares after meeting with its CEO to discuss the company's Phase 1b study evaluating lead candidate GT-02287 in Parkinson's disease. The CSF biomarker data expected in Q4 makes most sense 'to gain preliminary conviction' as it better capitulates pathological changes associated with iPD and GBA1-PD vs. serum biomarker analysis, the analyst tells investors in a research note. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
